English
简体中文
Total: £ 56.28
Published Date: 2025-11-06 | Pages: 164 | Tables: 155 | Pharma & Healthcare
The global NAD+Anti-Ageing Supplements market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
NAD+ anti-aging supplements generally refer to dietary supplements designed to increase levels of nicotinamide adenine dinucleotide (NAD+) in the body.NAD+ therapy helps to slow down the aging process of the body's cells, maintains the normal functioning of various cells, and maintains a youthful state in the human body.
From a downstream perspective, Online accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
NAD+Anti-Ageing Supplements leading manufacturers including Chromadex, Kingdomway, GeneHarbor, CELFULL, MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical), Bontac, Herbalmax, Maac10 Formulas, EffePharm, Elysium Health, etc., dominate supply; the top five capture approximately % of global revenue, with Chromadex leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global NAD+Anti-Ageing Supplements market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Chromadex
Kingdomway
GeneHarbor
CELFULL
MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical)
Bontac
Herbalmax
Maac10 Formulas
EffePharm
Elysium Health
Genex Formulas
NOMON Co., Ltd. (Teijin)
EZZ
Segment by Type
NAD+ Capsules
NAD+ Tablet
Others
Segment by Application
Online
Offline
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the NAD+Anti-Ageing Supplements study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to NAD+Anti-Ageing Supplements: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global NAD+Anti-Ageing Supplements Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 NAD+ Capsules
1.2.3 NAD+ Tablet
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global NAD+Anti-Ageing Supplements Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Online
1.3.3 Offline
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global NAD+Anti-Ageing Supplements Revenue Estimates and Forecasts 2020-2031
2.2 Global NAD+Anti-Ageing Supplements Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global NAD+Anti-Ageing Supplements Sales Estimates and Forecasts 2020-2031
2.4 Global NAD+Anti-Ageing Supplements Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global NAD+Anti-Ageing Supplements Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global NAD+Anti-Ageing Supplements Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 NAD+ Capsules Market Size by Manufacturers
3.5.2 NAD+ Tablet Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global NAD+Anti-Ageing Supplements Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global NAD+Anti-Ageing Supplements Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global NAD+Anti-Ageing Supplements Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global NAD+Anti-Ageing Supplements Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global NAD+Anti-Ageing Supplements Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America NAD+Anti-Ageing Supplements Sales and Revenue by Type (2020-2031)
6.4 North America NAD+Anti-Ageing Supplements Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America NAD+Anti-Ageing Supplements Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe NAD+Anti-Ageing Supplements Sales and Revenue by Type (2020-2031)
7.4 Europe NAD+Anti-Ageing Supplements Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe NAD+Anti-Ageing Supplements Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific NAD+Anti-Ageing Supplements Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific NAD+Anti-Ageing Supplements Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific NAD+Anti-Ageing Supplements Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America NAD+Anti-Ageing Supplements Sales and Revenue by Type (2020-2031)
9.4 Central and South America NAD+Anti-Ageing Supplements Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America NAD+Anti-Ageing Supplements Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa NAD+Anti-Ageing Supplements Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa NAD+Anti-Ageing Supplements Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa NAD+Anti-Ageing Supplements Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Chromadex
11.1.1 Chromadex Corporation Information
11.1.2 Chromadex Business Overview
11.1.3 Chromadex NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.1.4 Chromadex NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Chromadex NAD+Anti-Ageing Supplements Sales by Product in 2024
11.1.6 Chromadex NAD+Anti-Ageing Supplements Sales by Application in 2024
11.1.7 Chromadex NAD+Anti-Ageing Supplements Sales by Geographic Area in 2024
11.1.8 Chromadex NAD+Anti-Ageing Supplements SWOT Analysis
11.1.9 Chromadex Recent Developments
11.2 Kingdomway
11.2.1 Kingdomway Corporation Information
11.2.2 Kingdomway Business Overview
11.2.3 Kingdomway NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.2.4 Kingdomway NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Kingdomway NAD+Anti-Ageing Supplements Sales by Product in 2024
11.2.6 Kingdomway NAD+Anti-Ageing Supplements Sales by Application in 2024
11.2.7 Kingdomway NAD+Anti-Ageing Supplements Sales by Geographic Area in 2024
11.2.8 Kingdomway NAD+Anti-Ageing Supplements SWOT Analysis
11.2.9 Kingdomway Recent Developments
11.3 GeneHarbor
11.3.1 GeneHarbor Corporation Information
11.3.2 GeneHarbor Business Overview
11.3.3 GeneHarbor NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.3.4 GeneHarbor NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 GeneHarbor NAD+Anti-Ageing Supplements Sales by Product in 2024
11.3.6 GeneHarbor NAD+Anti-Ageing Supplements Sales by Application in 2024
11.3.7 GeneHarbor NAD+Anti-Ageing Supplements Sales by Geographic Area in 2024
11.3.8 GeneHarbor NAD+Anti-Ageing Supplements SWOT Analysis
11.3.9 GeneHarbor Recent Developments
11.4 CELFULL
11.4.1 CELFULL Corporation Information
11.4.2 CELFULL Business Overview
11.4.3 CELFULL NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.4.4 CELFULL NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 CELFULL NAD+Anti-Ageing Supplements Sales by Product in 2024
11.4.6 CELFULL NAD+Anti-Ageing Supplements Sales by Application in 2024
11.4.7 CELFULL NAD+Anti-Ageing Supplements Sales by Geographic Area in 2024
11.4.8 CELFULL NAD+Anti-Ageing Supplements SWOT Analysis
11.4.9 CELFULL Recent Developments
11.5 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical)
11.5.1 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Corporation Information
11.5.2 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Business Overview
11.5.3 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.5.4 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) NAD+Anti-Ageing Supplements Sales by Product in 2024
11.5.6 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) NAD+Anti-Ageing Supplements Sales by Application in 2024
11.5.7 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) NAD+Anti-Ageing Supplements Sales by Geographic Area in 2024
11.5.8 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) NAD+Anti-Ageing Supplements SWOT Analysis
11.5.9 MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Recent Developments
11.6 Bontac
11.6.1 Bontac Corporation Information
11.6.2 Bontac Business Overview
11.6.3 Bontac NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.6.4 Bontac NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Bontac Recent Developments
11.7 Herbalmax
11.7.1 Herbalmax Corporation Information
11.7.2 Herbalmax Business Overview
11.7.3 Herbalmax NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.7.4 Herbalmax NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Herbalmax Recent Developments
11.8 Maac10 Formulas
11.8.1 Maac10 Formulas Corporation Information
11.8.2 Maac10 Formulas Business Overview
11.8.3 Maac10 Formulas NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.8.4 Maac10 Formulas NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Maac10 Formulas Recent Developments
11.9 EffePharm
11.9.1 EffePharm Corporation Information
11.9.2 EffePharm Business Overview
11.9.3 EffePharm NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.9.4 EffePharm NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 EffePharm Recent Developments
11.10 Elysium Health
11.10.1 Elysium Health Corporation Information
11.10.2 Elysium Health Business Overview
11.10.3 Elysium Health NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.10.4 Elysium Health NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Elysium Health Recent Developments
11.11 Genex Formulas
11.11.1 Genex Formulas Corporation Information
11.11.2 Genex Formulas Business Overview
11.11.3 Genex Formulas NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.11.4 Genex Formulas NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Genex Formulas Recent Developments
11.12 NOMON Co., Ltd. (Teijin)
11.12.1 NOMON Co., Ltd. (Teijin) Corporation Information
11.12.2 NOMON Co., Ltd. (Teijin) Business Overview
11.12.3 NOMON Co., Ltd. (Teijin) NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.12.4 NOMON Co., Ltd. (Teijin) NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 NOMON Co., Ltd. (Teijin) Recent Developments
11.13 EZZ
11.13.1 EZZ Corporation Information
11.13.2 EZZ Business Overview
11.13.3 EZZ NAD+Anti-Ageing Supplements Product Models, Descriptions and Specifications
11.13.4 EZZ NAD+Anti-Ageing Supplements Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 EZZ Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 NAD+Anti-Ageing Supplements Industry Chain
12.2 NAD+Anti-Ageing Supplements Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 NAD+Anti-Ageing Supplements Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 NAD+Anti-Ageing Supplements Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 NAD+Anti-Ageing Supplements Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global NAD+Anti-Ageing Supplements Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global NAD+Anti-Ageing Supplements Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global NAD+Anti-Ageing Supplements Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global NAD+Anti-Ageing Supplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global NAD+Anti-Ageing Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global NAD+Anti-Ageing Supplements Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global NAD+Anti-Ageing Supplements Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global NAD+Anti-Ageing Supplements Sales by Region (2020-2025) & (K Units)
Table 8. Global NAD+Anti-Ageing Supplements Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global NAD+Anti-Ageing Supplements Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global NAD+Anti-Ageing Supplements Sales Share by Manufacturers (2020-2025)
Table 12. Global NAD+Anti-Ageing Supplements Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global NAD+Anti-Ageing Supplements Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global NAD+Anti-Ageing Supplements by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+Anti-Ageing Supplements as of 2024)
Table 16. Global NAD+Anti-Ageing Supplements Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global NAD+Anti-Ageing Supplements Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers NAD+Anti-Ageing Supplements Manufacturing Base and Headquarters
Table 19. Global NAD+Anti-Ageing Supplements Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global NAD+Anti-Ageing Supplements Sales by Type (2020-2025) & (K Units)
Table 23. Global NAD+Anti-Ageing Supplements Sales by Type (2026-2031) & (K Units)
Table 24. Global NAD+Anti-Ageing Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global NAD+Anti-Ageing Supplements Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global NAD+Anti-Ageing Supplements ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global NAD+Anti-Ageing Supplements Sales by Application (2020-2025) & (K Units)
Table 29. Global NAD+Anti-Ageing Supplements Sales by Application (2026-2031) & (K Units)
Table 30. NAD+Anti-Ageing Supplements High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global NAD+Anti-Ageing Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global NAD+Anti-Ageing Supplements Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global NAD+Anti-Ageing Supplements ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America NAD+Anti-Ageing Supplements Growth Accelerators and Market Barriers
Table 37. North America NAD+Anti-Ageing Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America NAD+Anti-Ageing Supplements Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe NAD+Anti-Ageing Supplements Growth Accelerators and Market Barriers
Table 40. Europe NAD+Anti-Ageing Supplements Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe NAD+Anti-Ageing Supplements Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific NAD+Anti-Ageing Supplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific NAD+Anti-Ageing Supplements Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific NAD+Anti-Ageing Supplements Growth Accelerators and Market Barriers
Table 45. Southeast Asia NAD+Anti-Ageing Supplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America NAD+Anti-Ageing Supplements Investment Opportunities and Key Challenges
Table 47. Central and South America NAD+Anti-Ageing Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa NAD+Anti-Ageing Supplements Investment Opportunities and Key Challenges
Table 49. Middle East and Africa NAD+Anti-Ageing Supplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Chromadex Corporation Information
Table 51. Chromadex Description and Major Businesses
Table 52. Chromadex Product Models, Descriptions and Specifications
Table 53. Chromadex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Chromadex Sales Value Proportion by Product in 2024
Table 55. Chromadex Sales Value Proportion by Application in 2024
Table 56. Chromadex Sales Value Proportion by Geographic Area in 2024
Table 57. Chromadex NAD+Anti-Ageing Supplements SWOT Analysis
Table 58. Chromadex Recent Developments
Table 59. Kingdomway Corporation Information
Table 60. Kingdomway Description and Major Businesses
Table 61. Kingdomway Product Models, Descriptions and Specifications
Table 62. Kingdomway Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Kingdomway Sales Value Proportion by Product in 2024
Table 64. Kingdomway Sales Value Proportion by Application in 2024
Table 65. Kingdomway Sales Value Proportion by Geographic Area in 2024
Table 66. Kingdomway NAD+Anti-Ageing Supplements SWOT Analysis
Table 67. Kingdomway Recent Developments
Table 68. GeneHarbor Corporation Information
Table 69. GeneHarbor Description and Major Businesses
Table 70. GeneHarbor Product Models, Descriptions and Specifications
Table 71. GeneHarbor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. GeneHarbor Sales Value Proportion by Product in 2024
Table 73. GeneHarbor Sales Value Proportion by Application in 2024
Table 74. GeneHarbor Sales Value Proportion by Geographic Area in 2024
Table 75. GeneHarbor NAD+Anti-Ageing Supplements SWOT Analysis
Table 76. GeneHarbor Recent Developments
Table 77. CELFULL Corporation Information
Table 78. CELFULL Description and Major Businesses
Table 79. CELFULL Product Models, Descriptions and Specifications
Table 80. CELFULL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. CELFULL Sales Value Proportion by Product in 2024
Table 82. CELFULL Sales Value Proportion by Application in 2024
Table 83. CELFULL Sales Value Proportion by Geographic Area in 2024
Table 84. CELFULL NAD+Anti-Ageing Supplements SWOT Analysis
Table 85. CELFULL Recent Developments
Table 86. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Corporation Information
Table 87. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Description and Major Businesses
Table 88. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Product Models, Descriptions and Specifications
Table 89. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Sales Value Proportion by Product in 2024
Table 91. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Sales Value Proportion by Application in 2024
Table 92. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Sales Value Proportion by Geographic Area in 2024
Table 93. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) NAD+Anti-Ageing Supplements SWOT Analysis
Table 94. MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) Recent Developments
Table 95. Bontac Corporation Information
Table 96. Bontac Description and Major Businesses
Table 97. Bontac Product Models, Descriptions and Specifications
Table 98. Bontac Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Bontac Recent Developments
Table 100. Herbalmax Corporation Information
Table 101. Herbalmax Description and Major Businesses
Table 102. Herbalmax Product Models, Descriptions and Specifications
Table 103. Herbalmax Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Herbalmax Recent Developments
Table 105. Maac10 Formulas Corporation Information
Table 106. Maac10 Formulas Description and Major Businesses
Table 107. Maac10 Formulas Product Models, Descriptions and Specifications
Table 108. Maac10 Formulas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Maac10 Formulas Recent Developments
Table 110. EffePharm Corporation Information
Table 111. EffePharm Description and Major Businesses
Table 112. EffePharm Product Models, Descriptions and Specifications
Table 113. EffePharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. EffePharm Recent Developments
Table 115. Elysium Health Corporation Information
Table 116. Elysium Health Description and Major Businesses
Table 117. Elysium Health Product Models, Descriptions and Specifications
Table 118. Elysium Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Elysium Health Recent Developments
Table 120. Genex Formulas Corporation Information
Table 121. Genex Formulas Description and Major Businesses
Table 122. Genex Formulas Product Models, Descriptions and Specifications
Table 123. Genex Formulas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Genex Formulas Recent Developments
Table 125. NOMON Co., Ltd. (Teijin) Corporation Information
Table 126. NOMON Co., Ltd. (Teijin) Description and Major Businesses
Table 127. NOMON Co., Ltd. (Teijin) Product Models, Descriptions and Specifications
Table 128. NOMON Co., Ltd. (Teijin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. NOMON Co., Ltd. (Teijin) Recent Developments
Table 130. EZZ Corporation Information
Table 131. EZZ Description and Major Businesses
Table 132. EZZ Product Models, Descriptions and Specifications
Table 133. EZZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. EZZ Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. NAD+Anti-Ageing Supplements Product Picture
Figure 2. Global NAD+Anti-Ageing Supplements Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. NAD+ Capsules Product Picture
Figure 4. NAD+ Tablet Product Picture
Figure 5. Others Product Picture
Figure 6. Global NAD+Anti-Ageing Supplements Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Online
Figure 8. Offline
Figure 9. Others
Figure 10. NAD+Anti-Ageing Supplements Report Years Considered
Figure 11. Global NAD+Anti-Ageing Supplements Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 13. Global NAD+Anti-Ageing Supplements Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global NAD+Anti-Ageing Supplements Revenue Market Share by Region (2020-2031)
Figure 15. Global NAD+Anti-Ageing Supplements Sales (2020-2031) & (K Units)
Figure 16. Global NAD+Anti-Ageing Supplements Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global NAD+Anti-Ageing Supplements Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers NAD+Anti-Ageing Supplements Sales Volume Market Share in 2024
Figure 19. Global NAD+Anti-Ageing Supplements Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. NAD+ Capsules Revenue Market Share by Manufacturer in 2024
Figure 22. NAD+ Tablet Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global NAD+Anti-Ageing Supplements Sales Market Share by Type (2020-2031)
Figure 25. Global NAD+Anti-Ageing Supplements Revenue Market Share by Type (2020-2031)
Figure 26. Global NAD+Anti-Ageing Supplements Sales Market Share by Application (2020-2031)
Figure 27. Global NAD+Anti-Ageing Supplements Revenue Market Share by Application (2020-2031)
Figure 28. North America NAD+Anti-Ageing Supplements Sales YoY (2020-2031) & (K Units)
Figure 29. North America NAD+Anti-Ageing Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) in 2024
Figure 31. North America NAD+Anti-Ageing Supplements Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America NAD+Anti-Ageing Supplements Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 36. Canada NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 38. Europe NAD+Anti-Ageing Supplements Sales YoY (2020-2031) & (K Units)
Figure 39. Europe NAD+Anti-Ageing Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) in 2024
Figure 41. Europe NAD+Anti-Ageing Supplements Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe NAD+Anti-Ageing Supplements Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 46. France NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 48. Italy NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 49. Russia NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific NAD+Anti-Ageing Supplements Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific NAD+Anti-Ageing Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific NAD+Anti-Ageing Supplements Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific NAD+Anti-Ageing Supplements Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 58. Japan NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 61. India NAD+Anti-Ageing Supplements Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America NAD+Anti-Ageing Supplements Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America NAD+Anti-Ageing Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America NAD+Anti-Ageing Supplements Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America NAD+Anti-Ageing Supplements Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil NAD+Anti-Ageing Supplements Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina NAD+Anti-Ageing Supplements Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa NAD+Anti-Ageing Supplements Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa NAD+Anti-Ageing Supplements Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa NAD+Anti-Ageing Supplements Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa NAD+Anti-Ageing Supplements Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa NAD+Anti-Ageing Supplements Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries NAD+Anti-Ageing Supplements Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey NAD+Anti-Ageing Supplements Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt NAD+Anti-Ageing Supplements Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa NAD+Anti-Ageing Supplements Revenue (2020-2025) & (US$ Million)
Figure 82. NAD+Anti-Ageing Supplements Industry Chain Mapping
Figure 83. Regional NAD+Anti-Ageing Supplements Manufacturing Base Distribution (%)
Figure 84. Global NAD+Anti-Ageing Supplements Production Market Share by Region (2020-2031)
Figure 85. NAD+Anti-Ageing Supplements Production Process
Figure 86. Regional NAD+Anti-Ageing Supplements Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
